Moscow, November 15, 2019, 15:00 — 17:30
Webinar: Moscow — New York-Seoul
We conduct the simposium as part of the educational program dealing with controversies in glaucoma. The simposium aims to enhance the insight of eye specialists about development, diagnosis, and progression of glaucoma as well as to open a dialog between Russian and foreign professionals on the most long-standing glaucoma-related controversies.
Opening of the symposium and presentation of speakers
The introduction and greetings
Glaucoma progression: epidemiological studies, risk factors and predictors
The lecture covers the history of the first multicenter studies that have started in the earliest 2000-s. The controversies in this issue and the results of the main multicenter randomized trials are discussed, as well as there is a review of modern glaucoma studies focused on glaucoma pathogenesis with the use of all update visualization and genetics methods. Some projects on this issue are discussed in the presentation of Linda Zangwill (San-Diego, California), who is the coordinator of multicenter glaucoma trials.
How to detect glaucoma progression? the current concepts
The presentation emphasizes that simultaneous detection of both macular (ganglion cells + inner plexiform layer) and peripapillary retinal nerve fiber layer is a key point of the current concept of glaucoma progression detection. The clinical examples demonstrate that wide-field scanning permits to capture the earliest nerve tissue loss.
Glaucoma progression: the future options and perspectives
The presentation points out that the earliest changes in glaucoma starts in the inferior macular hemisphere that corresponds to the defects in the superior hemisphere of visual field. This precedes the loss of peripapillary retinal nerve fibers and was obtained in Normal Tension Glaucoma. The perspective methods of glaucoma diagnostics like SWEPT-Source OCT, adaptive optics and artificial intelligence are discussed.
Macular damage in glaucoma
The studies based on OCT, electrophysiological and histological methods were the first to describe the defects of macula where 30% of retinal ganglion cells are located. Detection of these defects is the key of early glaucoma diagnostics and monitoring.
Perfusion, phenotype and progression
The results of the multicenter studies conducted 20 years ago have clearly revealed the role of vascular factors, in particular, ocular perfusion pressure, in glaucoma progression. It has been obtained that anti-hypertensive treatment is a main cause of glaucoma progression. Different phenotypes define a tendency of each patient to a special course of the disease.
Discussion
Don Hood, the James F. Bender prof. of Psychology and prof. of Ophthalmic Science (in Ophthalmology), prof. of Ophthalmic ScienceDept Columbia University. The main field of his research are the physiological bases of both normal and abnormal visual processing of the retina or ganglion cell/optic nerve using electrophysiological and anatomical (OCT) techniques. While some of his over 300 publications deal with issues of the basic neuroscience of vision, most of his work over the last 25 years has concerned research on diseases of the retina and optic nerve. He is currently Editor-in-Chief of Investigative Ophthalmology and Visual Science, having served on its Board since 1992. He also serves on the Editorial Board of Journal of Glaucoma.
Dr. Christopher Leung is prof. and Head of Graduate Division of the Department of Ophthalmology & Visual Sciences at the Chinese University of Hong Kong (CUHK). He is a clinician-scientist with research focus on the investigation and management of glaucoma. Dr. Leung is investigating the cellular and molecular mechanisms of promoting retinal ganglion cell survival in glaucoma and other optic neuropathies. Не is also principle investigator of a number of clinical research projects studying the application of advanced optic disc and retinal nerve fiber layer imaging technologies in glaucoma diagnostics. Dr. Leung has received a number of international research awards.
prof. Ki Ho Park is prof. and Chairman of Ophthalmology, Seoul National University. He is a member of the Board of Governors of the World Glaucoma Association (WGA) and President-Elect of the Asia Pacific Glaucoma Society (APGS). He was Secretary General and Co-chair of South East Asian Glaucoma Interest Group (SEAGIG) Meeting and AACGC Meeting (2008, Seoul, Korea) Organizing Committee. He is an awardee of a number of international research awards. prof. Park has published more than 150 papers in international peer reviewed SCI journals. He was Editor of 'Atlas of Angle Closure Glaucoma' (2010) and Associate Editor of 'Angle Closure Glaucoma' (2007). His research interest includes risk factors of glaucoma, RNFL and ganglion cell imaging, normal-tension glaucoma, angle-closure glaucoma, and neuroprotection. He is the current President of Korean Ophthalmological Society.
Dr. Jeffrey M. Liebmann is a prof. of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection.
Head of the Department of Eye Diseases of the Federal Medical and Biological University of Innovations and Continuing Education of the FMBA of Russia; Professor of the Department of Ophthalmology of the APO of the FSBI FNCC of the FMBA of Russia; Head of the Consultative and Diagnostic Department of the Center of Ophthalmology of the FMBA of Russia; a member of the European Glaucoma Society and the American Academy of Ophthalmology; honorary member of the Italian Glaucoma Society; scientific supervisor and coordinator of the Federal Target Group Programs «Glaucoma Opticoneuropathy». Natalia is a representative of Russian Ophthalmology in the European Association of Predictive, Preventive and Personalized Medicine. The research interests: etiology, pathogenesis, laser and surgical treatment of glaucoma, neuroprotection, angle-closure, normotensive and pseudoexfoliative glaucoma, retinal diseases. For the last 10 years, she has been studying new methods of optic nerve and retina visualization in glaucoma, the progression of the disease, and ocular blood flow and the personalized treatment of the primary angle clouser. Author of more than 300 scientific papers, including 50 papers in international peer-reviewed journals, 10 monographs on the diagnosis and treatment of glaucoma and ocular blood flow, as well as 10 patents for inventions. Member of the editorial board of the National Journal of Glaucoma (Russia) and Ophthalmology Journal (Russia), a reviewer of the British Journal of Ophthalmology (BJO), Bulletin of Ophthalmology and other prominent international journals. She was awarded by the Ministry of Education of the Russian Federation for scientific research on topical issues of fundamental and applied science in the field of education, achievements in the training of highly qualified specialists, for the introduction of new forms and methods of teaching in the educational process. The author of two recent monographs: COVID-19 and visual organ damage, 2021, and Dry age-related macular degenerations, 2021, a member of International Optical Circulation Society (IOCS).